1.
|
11 p, 771.0 KB |
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
/
Cabrera Serrano, Antonio José (Instituto de Investigación Sanitaria de Granada) ;
Sánchez Maldonado, José Manuel (Instituto de Investigación Sanitaria de Granada) ;
ter Horst, Rob (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences) ;
Macauda, Angelica (German Cancer Research Center) ;
García Martín, Paloma (Hospital Campus de la Salud (Granada)) ;
Benavente, Yolanda (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Landi, Stefano (Department of Biology. University of Pisa) ;
Clay-Gilmour, Alyssa (Department of Epidemiology & Biostatistics. Arnold School of Public Health. University of South Carolina) ;
Niazi, Yasmeen (Hopp Children's Cancer Center) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Rodriguez-Sevilla, Juan Jose (Department of Leukemia. The University of Texas MD Anderson Cancer Center) ;
Pérez, Eva María (Hospital Campus de la Salud) ;
Maffei, Rossana (University of Modena and Reggio Emilia) ;
Blanco, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Giaccherini, Matteo (Department of Biology. University of Pisa) ;
Cerhan, James R. (Department of Quantitative Health Sciences. Mayo Clinic) ;
Marasca, Roberto (Department of Medical and Surgical Sciences. University of Modena and Reggio Emilia. AOU Policlinico) ;
Lopez Nevot, Miguel Angel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Chen-Liang, Tzu Hua (Hospital Universitario Morales Meseguer (Múrcia)) ;
Thomsen, Hauke (MSB Medical School Berlin) ;
Gámez, Irene (Hematology Department. Morales Meseguer University Hospital) ;
Campa, Daniele (Department of Biology. University of Pisa) ;
Moreno Aguado, Víctor (Facultat de Medicina. Universitat de Barcelona) ;
de Sanjosé, Silvia (Universitat de Barcelona) ;
Marcos-Gragera, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García-Álvarez, María Flor (Instituto de Investigación Biomédica de Salamanca) ;
Dierssen-Sotos, Trinidad (Universidad de Cantabria) ;
Jerez, Andrés (Vall d'Hebron Institut d'Oncologia) ;
Butrym, Aleksandra (Department of Cancer Prevention and Therapy. Medical University of Wrocław) ;
Norman, Aaron D. (Department of Quantitative Health Sciences. Mayo Clinic) ;
Luppi, Mario (University of Modena and Reggio Emilia) ;
Slager, Susan L. (Mayo Clinic) ;
Hemminki, Kari (Charles University in Prague) ;
Li, Yang (Hannover Medical School) ;
Berndt, Sonja I. (National Institutes of Health (Estats Units d'Amèrica)) ;
Casabonne, Delphine (Universitat de Barcelona) ;
Alcoceba, Miguel (Instituto de Investigación Biomédica de Salamanca) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Netea, Mihai G. (Department for Immunology & Metabolism. University of Bonn) ;
Försti, Asta (Hopp Children's Cancer Center) ;
Canzian, Federico (German Cancer Research Center) ;
Sainz, Juan (Department of Biochemistry and Molecular Biology. Universidad de Granada)
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. [...]
2023 - 10.3390/ijms24098005
International journal of molecular sciences, Vol. 24 Núm. 9 (may 2023) , p. 8005
|
|
2.
|
6 p, 1.5 MB |
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia : a CRuCIAL study
/
García Martín, Paloma (Hospital Campus de la Salud (Granada)) ;
Moñiz Díez, Ana (Instituto de Investigación Sanitaria de Granada) ;
Sánchez Maldonado, José Manuel (Instituto de Investigación Sanitaria de Granada) ;
Cabrera Serrano, Antonio José (Instituto de Investigación Sanitaria de Granada) ;
ter Horst, Rob (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences) ;
Benavente, Yolanda (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Landi, Stefano (Department of Biology. University of Pisa) ;
Macauda, Angelica (German Cancer Research Center) ;
Clay-Gilmour, Alyssa (University of South Carolina) ;
Hernández-Mohedo, Francisca (Instituto de Investigación Sanitaria de Granada) ;
Niazi, Yasmeen (Hopp Children's Cancer Center) ;
González-Sierra, Pedro Antonio (Instituto de Investigación Sanitaria de Granada) ;
Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Rodriguez-Sevilla, Juan Jose (Hospital del Mar (Barcelona, Catalunya)) ;
Maffei, Rossana (Department of Medical and Surgical Sciences. University of Modena and Reggio Emilia) ;
Blanco, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Giaccherini, Matteo (Department of Biology. University of Pisa) ;
Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Cerhan, James (Mayo Clinic) ;
Marasca, Roberto (Department of Medical and Surgical Sciences. University of Modena and Reggio Emilia) ;
Cañadas-Garre, Marisa (Instituto de Investigación Sanitaria de Granada) ;
Lopez Nevot, Miguel Angel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Chen-Liang, Tzu (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Thomsen, Hauke (ProtaGene CGT GmbH (Alemanya)) ;
Gámez, Irene (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Morros, Rosa (Institut d'Investigació Biomèdica de Bellvitge) ;
Marcos-Gragera, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García-Álvarez, María (Hospital Universitario de Salamanca) ;
Llorca, Javier (Universidad de Cantabria) ;
Jerez, Andrés (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Berndt, Sonja (National Institutes of Health (Estats Units d'Amèrica)) ;
Butrym, Aleksandra (Medical University of Wrocław) ;
Norman, Aaron D. (Mayo Clinic) ;
Casabonne, Delphine (CCIBER Epidemiología y Salud Pública (Madrid)) ;
Luppi, Mario (Department of Medical and Surgical Sciences. University of Modena and Reggio Emilia) ;
Slager, Susan L. (Mayo Clinic) ;
Hemminki, Kari (Charles University in Prague) ;
Li, Yang (CHannover Medical School) ;
Alcoceba, Miguel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Campa, Daniele (Department of Biology. University of Pisa) ;
Canzian, Federico (German Cancer Research Center (Alemanya)) ;
De Sanjose, Silvia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Försti, Asta (Hopp Children's Cancer Center) ;
Netea, Mihai G. (University of Bonn) ;
Jurado, Manuel (Instituto de Investigación Sanitaria de Granada) ;
Sainz, Juan (Universidad de Granada. Departamento de Bioquímica y Biología Molecular) ;
Universitat Autònoma de Barcelona
2022 - 10.1038/s41408-022-00676-8
Blood Cancer Journal, Vol. 12 Núm. 5 (may 2022) , p. 79
|
|
3.
|
9 p, 1.7 MB |
Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients
/
Stephens, Camilla (Instituto de Investigación Biomédica de Málaga) ;
Moreno-Casares, Antonia (Universidad de Granada) ;
López-Nevot, Miguel-Ángel (Universidad de Granada) ;
Garcia-Cortes, Miren (Instituto de Investigación Biomédica de Málaga) ;
Medina-Cáliz, Inmaculada (Instituto de Investigación Biomédica de Málaga) ;
Hallal, Hacibe (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Soriano, German (Institut d'Investigació Biomèdica Sant Pau) ;
Roman, Eva (Institut d'Investigació Biomèdica Sant Pau) ;
Ruiz-Cabello, Francisco (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Romero-Gómez, Manuel (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Lucena, M. Isabel (Instituto de Investigación Biomédica de Málaga) ;
Andrade, Raúl J. (Instituto de Investigación Biomédica de Málaga) ;
Universitat Autònoma de Barcelona
Natural killer cells are an integral part of the immune system and represent a large proportion of the lymphocyte population in the liver. The activity of these cells is regulated by various cell surface receptors, such as killer Ig-like receptors (KIR) that bind to human leukocyte antigen (HLA) class I ligands on the target cell. [...]
2016 - 10.3389/fphar.2016.00280
Frontiers in Pharmacology, Vol. 7 (august 2016)
|
|
4.
|
|
5.
|
17 p, 1.3 MB |
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
/
Betancor, Gilberto (Centro de Biología Molecular Severo Ochoa) ;
Garriga, César (Centro Nacional de Epidemiología (Espanya)) ;
Puertas, Maria C.. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Nevot Banús, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Anta, Lourdes (Hospital Carlos III (Madrid)) ;
Blanco, José L. (Hospital Clínic i Provincial de Barcelona) ;
Pérez Elías, M. Jesús (Hospital Universitario Ramón y Cajal (Madrid)) ;
Mendoza, Carmen de (Hospital Carlos III (Madrid)) ;
Martínez, Miguel A. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Menéndez-Arias, Luis (Centro de Biología Molecular Severo Ochoa) ;
Spanish AIDS Research Network (ResRIS)
Background: Thymidine analogue resistance mutations (TAMs) selected under treatment with nucleoside analogues generate two distinct genotypic profiles in the HIV-1 reverse transcriptase (RT): (i) TAM1: M41L, L210W and T215Y, and (ii) TAM2: D67N, K70R and K219E/Q, and sometimes T215F. [...]
2012 - 10.1186/1742-4690-9-68
Retrovirology, Vol. 9, N. 68 (13 August 2012) , p. 1-17
2 documents
|
|
6.
|
12 p, 786.4 KB |
Changes in codon-pair bias of human immunodeficiency virus type 1 have profound effects on virus replication in cell culture
/
Martrus, Gloria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Nevot Banús, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Andrés, Cristina (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Martinez, Miguel Ángel (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa)
Background: Human immunodeficiency virus type 1 (HIV-1) has a biased nucleotide composition different from human genes. This raises the question of how evolution has chosen the nucleotide sequence of HIV-1 that is observed today, or to what extent the actual encoding contributes to virus replication capacity, evolvability and pathogenesis. [...]
2013 - 10.1186/1742-4690-10-78
Retrovirology, Vol. 10, N. 78 (25 July 2013) , p. 1-12
6 documents
|
|